Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-03-005637
Filing Date
2003-09-16
Accepted
2003-09-16 15:37:32
Documents
1
Period of Report
2003-09-03

Document Format Files

Seq Description Document Type Size
1 debernardis_ex.html 4  
1 debernardis_ex.xml 4 3419
  Complete submission text file 0001144204-03-005637.txt   5369
Mailing Address 420 LEXINGTON AVENUE SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 300 NEW YORK NY 10170 212-297-6221
HEMOXYMED INC (Issuer) CIK: 0000872947 (see all company filings)

EIN.: 391661164 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2500 COLONY AVENUE LINDENHURST IL 60046
Business Address 2500 COLONY AVENUE LINDENHURST IL 60046 8473566451
DEBERNARDIS JOHN F (Reporting) CIK: 0001263233 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13835 | Film No.: 03897642